US Stock MarketDetailed Quotes

MDxHealth (MDXH)

Watchlist
  • 0.5430
  • -0.0187-3.33%
Close Jun 18 16:00 ET
  • 0.5599
  • +0.0169+3.11%
Post 18:24 ET
27.89MMarket Cap-0.84P/E (TTM)

MDxHealth (MDXH) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.31%-1.49M
88.19%-2.19M
112.12%378K
129.58%1.66M
62.67%-1.6M
52.28%-2.63M
13.80%-18.53M
57.72%-3.12M
-31.84%-5.62M
23.51%-4.28M
Net income from continuing operations
-59.18%-7.3M
41.72%-14.41M
-14.19%-5.26M
56.63%-2.64M
74.17%-1.92M
30.53%-4.59M
9.53%-24.72M
26.93%-4.61M
-33.57%-6.09M
4.20%-7.42M
Depreciation and amortization
6.36%2.39M
14.54%9.21M
11.31%2.44M
4.93%2.25M
26.03%2.27M
18.26%2.25M
17.20%8.04M
38.62%2.19M
15.17%2.15M
1.24%1.8M
Other non cash items
-98.06%12K
-387.41%-822K
-91.64%31K
-218.28%-923K
-366.50%-549K
62,000.00%619K
-32.07%286K
155.86%371K
30.95%-290K
273.11%206K
Change In working capital
318.83%2.85M
124.34%939K
248.62%2.59M
229.14%2.26M
-527.21%-2.61M
-33.03%-1.3M
-82.41%-3.86M
42.06%-1.74M
-32.08%-1.75M
63.54%610K
-Change in receivables
129.36%325K
171.92%2.32M
821.94%2.86M
173.95%545K
101.71%24K
20.47%-1.11M
-91.68%-3.23M
110.47%310K
-61.98%-737K
-201.44%-1.41M
-Change in inventory
-215.65%-628K
-77.16%-1.93M
-206.41%-548K
-69.21%-1.07M
-21.13%-860K
304.91%543K
-141.15%-1.09M
478.65%515K
-224.74%-630K
-10.25%-710K
-Change in payables and accrued expense
527.41%3.15M
20.09%550K
110.76%276K
826.11%2.78M
-164.91%-1.77M
-208.54%-737K
2,190.00%458K
-1,858.02%-2.57M
43.34%-383K
837.03%2.73M
Cash from discontinued investing activities
Operating cash flow
43.31%-1.49M
88.19%-2.19M
112.12%378K
129.58%1.66M
62.67%-1.6M
52.28%-2.63M
13.80%-18.53M
57.72%-3.12M
-31.84%-5.62M
23.51%-4.28M
Investing cash flow
Cash flow from continuing investing activities
-3,946.15%-500K
-1,034.35%-18.56M
882.97%1.79M
-5,861.54%-775K
-2,424.36%-19.59M
102.10%13K
58.38%-1.64M
66.12%-229K
97.04%-13K
50.82%-776K
Net PPE purchase and sale
23.95%-362K
2.61%-1.16M
71.88%-54K
-25.24%-263K
35.69%-364K
-116.36%-476K
56.75%-1.19M
44.83%-192K
14.63%-210K
58.57%-566K
Net intangibles purchase and sale
----
--0
--0
--0
--0
--0
57.26%-971K
--0
--0
18.67%-427K
Net business purchase and sale
----
--755K
--21.25M
---839K
----
----
--0
--0
--0
----
Net other investing changes
---329K
-3,441.98%-19.66M
----
----
----
----
---555K
----
----
----
Cash from discontinued investing activities
Investing cash flow
-3,946.15%-500K
-1,034.35%-18.56M
882.97%1.79M
-5,861.54%-775K
-2,424.36%-19.59M
102.10%13K
58.38%-1.64M
66.12%-229K
97.04%-13K
50.82%-776K
Financing cash flow
Cash flow from continuing financing activities
-25.00%16.12M
-93.35%2.97M
-682.92%-5.15M
-105.01%-1.68M
-198.10%-11.69M
1,326.37%21.49M
38.16%44.6M
138.55%884K
1,581.41%33.55M
936.52%11.91M
Net issuance payments of debt
-20.65%18.71M
86.43%21.6M
-501.60%-752K
63.55%-538K
-104.90%-678K
3,812.13%23.57M
454.48%11.59M
86.25%-125K
-10.98%-1.48M
2,738.17%13.82M
Net common stock issuance
----
--0
--0
----
----
----
2.88%40.74M
--3.53M
--37.21M
--0
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net other financing activities
-10.24%-140K
-767.48%-8.91M
-156.03%-1.85M
995.15%1.48M
-29,110.34%-8.41M
25.29%-127K
-133.41%-1.03M
---721K
---165K
--29K
Cash from discontinued financing activities
Financing cash flow
-25.00%16.12M
-93.35%2.97M
-682.92%-5.15M
-105.01%-1.68M
-198.10%-11.69M
1,326.37%21.49M
38.16%44.6M
138.55%884K
1,581.41%33.55M
936.52%11.91M
Net cash flow
Beginning cash position
-37.96%29.03M
109.11%46.8M
-35.03%32.01M
53.72%32.81M
353.10%65.67M
109.11%46.8M
44.36%22.38M
50.61%49.27M
-45.93%21.34M
-69.96%14.49M
Current changes in cash
-25.14%14.12M
-172.78%-17.78M
-21.07%-2.98M
-102.85%-795K
-579.32%-32.87M
339.28%18.87M
256.57%24.43M
76.19%-2.46M
500.83%27.92M
179.79%6.86M
Effect of exchange rate changes
-128.57%-2K
214.29%16K
--0
-133.33%-2K
237.50%11K
800.00%7K
-156.00%-14K
-222.22%-11K
-97.12%6K
95.72%-8K
End cash Position
-34.29%43.15M
-37.96%29.03M
-37.96%29.03M
-35.03%32.01M
53.72%32.81M
353.10%65.67M
109.11%46.8M
109.11%46.8M
50.61%49.27M
-45.93%21.34M
Free cash flow
40.35%-1.85M
83.83%-3.35M
109.79%324K
124.00%1.4M
62.80%-1.96M
50.50%-3.11M
21.98%-20.69M
60.51%-3.31M
-13.40%-5.83M
29.57%-5.27M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.31%-1.49M88.19%-2.19M112.12%378K129.58%1.66M62.67%-1.6M52.28%-2.63M13.80%-18.53M57.72%-3.12M-31.84%-5.62M23.51%-4.28M
Net income from continuing operations -59.18%-7.3M41.72%-14.41M-14.19%-5.26M56.63%-2.64M74.17%-1.92M30.53%-4.59M9.53%-24.72M26.93%-4.61M-33.57%-6.09M4.20%-7.42M
Depreciation and amortization 6.36%2.39M14.54%9.21M11.31%2.44M4.93%2.25M26.03%2.27M18.26%2.25M17.20%8.04M38.62%2.19M15.17%2.15M1.24%1.8M
Other non cash items -98.06%12K-387.41%-822K-91.64%31K-218.28%-923K-366.50%-549K62,000.00%619K-32.07%286K155.86%371K30.95%-290K273.11%206K
Change In working capital 318.83%2.85M124.34%939K248.62%2.59M229.14%2.26M-527.21%-2.61M-33.03%-1.3M-82.41%-3.86M42.06%-1.74M-32.08%-1.75M63.54%610K
-Change in receivables 129.36%325K171.92%2.32M821.94%2.86M173.95%545K101.71%24K20.47%-1.11M-91.68%-3.23M110.47%310K-61.98%-737K-201.44%-1.41M
-Change in inventory -215.65%-628K-77.16%-1.93M-206.41%-548K-69.21%-1.07M-21.13%-860K304.91%543K-141.15%-1.09M478.65%515K-224.74%-630K-10.25%-710K
-Change in payables and accrued expense 527.41%3.15M20.09%550K110.76%276K826.11%2.78M-164.91%-1.77M-208.54%-737K2,190.00%458K-1,858.02%-2.57M43.34%-383K837.03%2.73M
Cash from discontinued investing activities
Operating cash flow 43.31%-1.49M88.19%-2.19M112.12%378K129.58%1.66M62.67%-1.6M52.28%-2.63M13.80%-18.53M57.72%-3.12M-31.84%-5.62M23.51%-4.28M
Investing cash flow
Cash flow from continuing investing activities -3,946.15%-500K-1,034.35%-18.56M882.97%1.79M-5,861.54%-775K-2,424.36%-19.59M102.10%13K58.38%-1.64M66.12%-229K97.04%-13K50.82%-776K
Net PPE purchase and sale 23.95%-362K2.61%-1.16M71.88%-54K-25.24%-263K35.69%-364K-116.36%-476K56.75%-1.19M44.83%-192K14.63%-210K58.57%-566K
Net intangibles purchase and sale ------0--0--0--0--057.26%-971K--0--018.67%-427K
Net business purchase and sale ------755K--21.25M---839K----------0--0--0----
Net other investing changes ---329K-3,441.98%-19.66M-------------------555K------------
Cash from discontinued investing activities
Investing cash flow -3,946.15%-500K-1,034.35%-18.56M882.97%1.79M-5,861.54%-775K-2,424.36%-19.59M102.10%13K58.38%-1.64M66.12%-229K97.04%-13K50.82%-776K
Financing cash flow
Cash flow from continuing financing activities -25.00%16.12M-93.35%2.97M-682.92%-5.15M-105.01%-1.68M-198.10%-11.69M1,326.37%21.49M38.16%44.6M138.55%884K1,581.41%33.55M936.52%11.91M
Net issuance payments of debt -20.65%18.71M86.43%21.6M-501.60%-752K63.55%-538K-104.90%-678K3,812.13%23.57M454.48%11.59M86.25%-125K-10.98%-1.48M2,738.17%13.82M
Net common stock issuance ------0--0------------2.88%40.74M--3.53M--37.21M--0
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Net other financing activities -10.24%-140K-767.48%-8.91M-156.03%-1.85M995.15%1.48M-29,110.34%-8.41M25.29%-127K-133.41%-1.03M---721K---165K--29K
Cash from discontinued financing activities
Financing cash flow -25.00%16.12M-93.35%2.97M-682.92%-5.15M-105.01%-1.68M-198.10%-11.69M1,326.37%21.49M38.16%44.6M138.55%884K1,581.41%33.55M936.52%11.91M
Net cash flow
Beginning cash position -37.96%29.03M109.11%46.8M-35.03%32.01M53.72%32.81M353.10%65.67M109.11%46.8M44.36%22.38M50.61%49.27M-45.93%21.34M-69.96%14.49M
Current changes in cash -25.14%14.12M-172.78%-17.78M-21.07%-2.98M-102.85%-795K-579.32%-32.87M339.28%18.87M256.57%24.43M76.19%-2.46M500.83%27.92M179.79%6.86M
Effect of exchange rate changes -128.57%-2K214.29%16K--0-133.33%-2K237.50%11K800.00%7K-156.00%-14K-222.22%-11K-97.12%6K95.72%-8K
End cash Position -34.29%43.15M-37.96%29.03M-37.96%29.03M-35.03%32.01M53.72%32.81M353.10%65.67M109.11%46.8M109.11%46.8M50.61%49.27M-45.93%21.34M
Free cash flow 40.35%-1.85M83.83%-3.35M109.79%324K124.00%1.4M62.80%-1.96M50.50%-3.11M21.98%-20.69M60.51%-3.31M-13.40%-5.83M29.57%-5.27M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More